At the news
? NEUTRALIMPACT 2/10 6-K filed Sep 9, 2026 at 16:01 ET
Purple Biotech Ltd. filed a 6-K on September 9, 2026, reporting the results of its Annual General Meeting of Shareholders held on September 8, 2026. All proposals presented at the meeting were approved by the requisite shareholder vote. This is a routine procedural filing with no material financial or operational impact.
- Annual General Meeting held on September 8, 2026.
- All proposals were approved by shareholders.
- Filing is a routine report of meeting results.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access